4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001649904-26-000030
Director sold 10,000 shares at an average $109.66 ($1,096,550)
- Director acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
JEAN CHRISTOPHE · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-17 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,000 | $34.89 | $348,900 | 21,712 | D |
| 2026-11-17 | Sale : show line 2 in the form 10b5-1 | −5,000 | $106.81 | $534,050 | 16,712 | D |
| 2026-11-17 | Sale : show line 3 in the form 10b5-1 | −2,500 | $110.00 | $275,000 | 14,212 | D |
| 2026-11-17 | Sale : show line 4 in the form 10b5-1 | −2,500 | $115.00 | $287,500 | 11,712 | D |
| Open-market sales · 10,000 sh · avg $109.66 · $1,096,550 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2026-11-17 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Options (Right to Buy) | −10,000 | $34.89 | 2028-06-05 | 10,000 | 0 | D |
Loading xslF345X06/form4.xml…